The top 30 finalists of the >>venture>> competition in the categories Hardware, Health & Nutrition, and Software & Services have been announced. Congratulations EraCal Therapeutics and Legartis for joining the finalists!

Switzerland is the European leader with its strong biotech start-up ecosystem. According to "nature biotechnology", Switzerland ranks first place in scientific output, patenting activity, and venture capital availability.

The University of Zurich belongs to the most innovative universities in Europe. This is reconfirmed by the Reuters TOP 100 ranking "Europe's Most Innovative Universities": The UZH ranks ninth.

Hookipa Pharma, a University of Zurich (UZH) spin-off company, made its initial public offering (IPO) at Nasdaq in New York.

The paper focuses on the role of research-intensive universities in stimulating and supporting initiatives and programmes related to student entrepreneurship, but also on their role as drivers of entrepreneurial ecosystems.  

UZH molecular biologist Prajwal and a team of researchers have developed a comprehensive rapid diagnostic test for multi-resistant tuberculosis pathogens. He now wants to turn the test into a commercial product with the help of a UZH Entrepreneur Fellowship.

Yannick Devaud, a Post-doctoral fellow at the University Hospital Zurich, is one of the four winners of Venture Kick Winners Nationwide.

Wie entsteht Innovation und wie gelingt der Sprung von der Wissenschaft in die Wirtschaft? Darüber sprachen die Jung-Unternehmerin Claudia Winkler und der Biochemiker und Spin-off-Pionier Andreas Plückthun im Talk im Turm.

Let us introduce you to the Startup & Innovation World. Find unique internships and get a chance to get into untested waters. Get prepared for the Future of Work. Become a Future.preneur.

UZH spin-off Anaveon successfully closed a CHF 35 million Series A financing with the lead investor Syncona Ltd. based in the a UK.